Last update 21 Dec 2024
Mifcare

Mifcare

Private Company|
2013|
France
|
< 10
|
mifcare.com

Overview

Tags

Other Diseases
Respiratory Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Immune System Diseases1
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
MIF(Macrophage migration inhibitory factor)1
MIF x NLRP31

Related

2
Drugs associated with Mifcare
MFC-1040
Target
MIF x NLRP3
Mechanism
MIF inhibitors [+1]
Active Org.
Institut National de la Santé et de la Recherche MédicaleInstitut National de la Santé et de la Recherche Médicale [+5]
Originator Org.
MifcareMifcare
Active Indication
Asthma [+2]
Inactive Indication
Gout
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
MFC-2040
Target
MIF
Mechanism
MIF inhibitors
Active Org.
MifcareMifcare
Originator Org.
MifcareMifcare
Active Indication
Pulmonary Arterial Hypertension
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Mifcare
Login to view more data
0 Patents (Medical) associated with Mifcare
Login to view more data
100 Deals associated with Mifcare
Login to view more data
100 Translational Medicine associated with Mifcare
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
MFC-2040
 ( MIF )		Pulmonary Arterial Hypertension
More
Preclinical
MFC-1040
 ( MIF x NLRP3 )		Pulmonary Arterial Hypertension
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free